Literature DB >> 18385666

Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.

T Tejada1, P Catanuto, A Ijaz, J V Santos, X Xia, P Sanchez, N Sanabria, O Lenz, S J Elliot, A Fornoni.   

Abstract

Loss of podocytes by apoptosis characterizes the early stages of diabetic nephropathy. To examine its mechanism we studied glomeruli and podocytes isolated from db/db mice with early diabetic nephropathy and albuminuria. Phosphorylation of AKT (protein kinase B, a key survival protein) was found to be lower in the glomeruli of 12 week old db/db compared to db/+ mice. In vitro, insulin phosphorylated AKT solely in podocytes from db/+ mice. Serum deprivation and exposure to tumor necrosis factor-alpha significantly compromised cell viability in podocytes from db/db but not from db/+ mice, and this was associated with a significant decrease in AKT phosphorylation. Inhibition of AKT was necessary to achieve the same degree of cell death in db/+ podocytes. Our study shows that podocyte inability to respond to insulin and susceptibility to cell death may partially account for the decreased podocyte number seen in early diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385666     DOI: 10.1038/ki.2008.109

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  72 in total

1.  Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Authors:  D K Kim; B Y Nam; J J Li; J T Park; S H Lee; D H Kim; J Y Kim; H Y Kang; S H Han; T H Yoo; D S Han; S W Kang
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

Review 2.  Roles of adaptor proteins in podocyte biology.

Authors:  Tae-Sun Ha
Journal:  World J Nephrol       Date:  2013-02-06

Review 3.  Obesity and renovascular disease.

Authors:  Xin Zhang; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-03

4.  Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

Authors:  Christopher E Pedigo; Gloria Michelle Ducasa; Farah Leclercq; Alexis Sloan; Alla Mitrofanova; Tahreem Hashmi; Judith Molina-David; Mengyuan Ge; Mariann I Lassenius; Carol Forsblom; Markku Lehto; Per-Henrik Groop; Matthias Kretzler; Sean Eddy; Sebastian Martini; Heather Reich; Patricia Wahl; GianMarco Ghiggeri; Christian Faul; George W Burke; Oliver Kretz; Tobias B Huber; Armando J Mendez; Sandra Merscher; Alessia Fornoni
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

Review 5.  The impact of insulin resistance on the kidney and vasculature.

Authors:  Ferruh Artunc; Erwin Schleicher; Cora Weigert; Andreas Fritsche; Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

6.  AKT2 is essential to maintain podocyte viability and function during chronic kidney disease.

Authors:  Guillaume Canaud; Frank Bienaimé; Amandine Viau; Caroline Treins; William Baron; Clément Nguyen; Martine Burtin; Sophie Berissi; Konstantinos Giannakakis; Andrea Onetti Muda; Stefan Zschiedrich; Tobias B Huber; Gérard Friedlander; Christophe Legendre; Marco Pontoglio; Mario Pende; Fabiola Terzi
Journal:  Nat Med       Date:  2013-09-22       Impact factor: 53.440

7.  Tyro3 is a podocyte protective factor in glomerular disease.

Authors:  Fang Zhong; Zhaohong Chen; Liwen Zhang; Yifan Xie; Viji Nair; Wenjun Ju; Matthias Kretzler; Robert G Nelson; Zhengzhe Li; Hongyu Chen; Yongjun Wang; Aihua Zhang; Kyung Lee; Zhihong Liu; John Cijiang He
Journal:  JCI Insight       Date:  2018-11-15

Review 8.  Signaling in regulation of podocyte phenotypes.

Authors:  Peter Y Chuang; John C He
Journal:  Nephron Physiol       Date:  2009-01-13

9.  Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.

Authors:  Jamie Lin; Yuanyuan Shi; Hui Peng; Xiaojie Shen; Sandhya Thomas; Yanlin Wang; Luan D Truong; Stuart E Dryer; Zhaoyong Hu; Jing Xu
Journal:  J Pathol       Date:  2015-02-19       Impact factor: 7.996

10.  In vivo 17β-estradiol treatment contributes to podocyte actin stabilization in female db/db mice.

Authors:  Paola Catanuto; Alessia Fornoni; Simone Pereira-Simon; Fayi Wu; Kerry L Burnstein; Xiaomei Xia; Francesco Conti; Andrea Lenzi; Sharon Elliot
Journal:  Endocrinology       Date:  2012-10-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.